Rivaroxaban Sandoz eco 20 mg, Filmtabletten - 100 Swissmedic Key 68693012 Registration Holder Sandoz Pharmaceuticals AG Name Rivaroxaban Sandoz eco 20 mg, Filmtabletten Date of registration 12.10.2023 Introduction of Sequence 12.10.2023 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until 11.10.2028 Index Therapeuticus (BSV) 06.03.40. Show package size 100 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680686930124 Medication Code Synthetika Pharmacode Disponibility
Composition rivaroxabanum 20 mg, natrii laurilsulfas, lactosum 29 mg, poloxamerum 188, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, E 171, macrogolum 3350, E 172 (rubrum), pro compresso obducto corresp. natrium 1.26 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Rivaroxabanum 20 mg
BAG: Active Agent Dose Rivaroxabanum 20 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hypromellosum Überzug Lactosum 29 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Poloxamer 188 Pro Compresso Obducto Silica Colloidalis Anhydrica
Source Data was imported : 08.11.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
